Spots Global Cancer Trial Database for Diamel in the Treatment of Polycystic Ovary Syndrome
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Diamel in the Treatment of Polycystic Ovary Syndrome
Official Title: Efficacy of Diamel in the Treatment of Polycystic Ovary Syndrome
Study ID: NCT01051024
Conditions
Study Description
Brief Summary: The purpose of this study is to assess the efficacy of Diamel administration in the treatment of Polycystic Ovary Syndrome. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
"Ramón González Coro" Gynecologic and Obstetric Hospital, Havana City, Havana, Cuba
Contact Details
Name: Mercedes Hernandez, MD
Affiliation: "Ramón González Coro" Gynecologic and Obstetric Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
